Código QR (código de barras bidimensional)

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study

Background: HIV and hepatitis B virus (HBV) coinfection has been associated with a higher risk of morbidity and mortality. HBV-active antiretroviral regimens have significantly improved the outcomes for coinfected people. Although bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is safe...

תיאור מלא

שמור ב:
Principais autores: Helena Kwakwa, Jacqueline Bran, Julia Ruff, Salma Sharaf, Hyunuk Seung, Sunny Choe, Joel V. Chua
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2025-03-01
סדרה:Viruses
נושאים:
HIV
hepatitis B
HIV-HBV coinfection
bictegravir
tenofovir alafenamide
גישה מקוונת:https://www.mdpi.com/1999-4915/17/4/510
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים